Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 17, 2022
Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraintsCharles T Lee, Samuel Litwin, Christopher M K L Yao, et al.Cancer Research|October 3, 2007
Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanismsJay E Johnson, Edward J Gettings, Jaclyn Schwalm, et al.COPD|October 12, 2013
Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodelingSalim Merali, Carlos A Barrero, Russell P Bowler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphomaRobert M Sharkey, Habibe Karacay, Christine R Johnson, et al.Virology|October 1, 2013
Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liverGeorget Y Reaiche-Miller, Michael Thorpe, Huey Chi Low, et al.Inflammatory Bowel Diseases|May 3, 2008
5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitisMargie L Clapper, Monique A Gary, Renata A Coudry, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinomaCorey J Langer, Robert Somer, Samuel Litwin, et al.Cancer Immunology Research|April 26, 2014
PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resectionAlexander W MacFarlane, Mowafaq Jillab, Elizabeth R Plimack, et al.Cancer Investigation|March 16, 2006
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancyCorey J Langer, Karen Duffy, Eric M Horwitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinomaYu-Ning Wong, Samuel Litwin, David Vaughn, et al.Pageof 7